MedPath

Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia

Not Applicable
Recruiting
Conditions
Endothelial Function (FMD)
Preeclampsia
Retinal Vessels
Registration Number
NCT07084727
Lead Sponsor
University Hospital, Antwerp
Brief Summary

Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • at least 18 years old
  • willing to undergo vascular assessments
  • informed consent signed
Exclusion Criteria
  • Unwilling to provide informed consent
  • Open-angle glaucoma
  • Epilepsia
  • (gestational) Diabetes
  • Multiple pregnancies
  • Fetal malformations
  • Hypercholesterolemia
  • Kidney disease
  • Auto-immune disorders
  • Connective tissue diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Retinal biomarkersBaseline

Early (retinal) biomarkers for cardiovascular risk in patients with preeclampsia, assessed by DVA.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Antwerp University Hospital

🇧🇪

Edegem, Antwerp, Belgium

Antwerp University Hospital
🇧🇪Edegem, Antwerp, Belgium
Studies cardiologie
Contact
+32 3 821 40 74
studies.cardiologie@uza.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.